Yoshihiro Miwa Selected Research

Yoshihiro Miwa Research Topics

Disease

9	Neoplasms (Cancer) 01/2017 - 07/2007
3	Breast Neoplasms (Breast Cancer) 01/2009 - 07/2005
2	Infections 01/2013 - 01/2012
2	Carcinoma (Carcinomatosis) 08/2009 - 07/2005
2	Squamous Cell Carcinoma of Head and Neck 07/2007 - 05/2005
1	Fibrosis (Cirrhosis) 11/2021
1	Drug-Related Side Effects and Adverse Reactions 05/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018
1	Lung Neoplasms (Lung Cancer) 12/2018
1	Disease Progression 12/2018
1	Atherosclerosis 01/2018
1	Hand-Foot Syndrome 01/2017
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2017
1	Neutropenia 01/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2016
1	Obesity 03/2016
1	Tissue Adhesions 11/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2013
1	Soft Tissue Infections 01/2013
1	Endocarditis 01/2013
1	Osteomyelitis 01/2013
1	Bacteremia 01/2013
1	Febrile Neutropenia 01/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2009
1	Vascular Remodeling 07/2008
1	Hypoxia (Hypoxemia) 07/2008
1	Neoplasm Metastasis (Metastasis) 07/2007
1	Body Weight (Weight, Body) 07/2007
1	Prostatic Neoplasms (Prostate Cancer) 09/2006
1	Genomic Instability 09/2006
1	Inflammation (Inflammations) 03/2006
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 04/2002

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 05/2005
2	Therapeutic UsesIBA 10/2014 - 01/2012
1	LipidsIBA 11/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2018
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	ProteomeIBA 12/2018
1	Prokaryotic Initiation Factor-3IBA 12/2018
1	Blocking AntibodiesIBA 12/2018
1	Interleukin-5 (Interleukin 5)IBA 12/2018
1	Interleukin-17 (Interleukin 17)IBA 12/2018
1	CholesterolIBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Methazolamide FDA LinkGeneric 01/2017
1	Proton Pump InhibitorsIBA 01/2017
1	Docetaxel (Taxotere)FDA Link 01/2017
1	Capecitabine (Xeloda)FDA Link 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2016
1	SeprafilmIBA 11/2015
1	Talc FDA Link 11/2015
1	Indicators and Reagents (Reagents)IBA 10/2014
1	Daptomycin FDA Link 01/2013
1	aplyronine AIBA 08/2012
1	Retinaldehyde (Retinal)IBA 07/2012
1	TeicoplaninIBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 08/2009
1	Inosine Monophosphate (IMP)IBA 08/2009
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 08/2009
1	Messenger RNA (mRNA)IBA 08/2009
1	LipoxygenasesIBA 08/2009
1	gosha-jinki-ganIBA 01/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2009
1	Transcription Factors (Transcription Factor)IBA 07/2008
1	Ephrin-A1 (Ephrin A1)IBA 07/2008
1	DNA (Deoxyribonucleic Acid)IBA 11/2007
1	plerixafor FDA Link 07/2007
1	Chemokine CXCL12IBA 07/2007
1	Androgen Receptors (Androgen Receptor)IBA 09/2006
1	AndrogensIBA 09/2006
1	IntegrinsIBA 03/2006
1	Diphtheria ToxinIBA 07/2005
1	titanium silicide (TS-1)IBA 05/2005
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 04/2002
1	trans-sodium crocetinate (crocetin)IBA 04/2002
1	Nuclear Export Signals (Nuclear Export Signal)IBA 04/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 12/2018 - 05/2005
2	Therapeutics 10/2014 - 07/2005